Abstract：Objective To investigate the clinical effect of pulmonary surfactant(PS)combined with Budesonide in the treatment of premature infants with neonatal respiratory distress syndrome(NRDS)and its effect on arterial blood gas status.Methods A total of 98 premature infants with severe NRDS admitted to Jinan Laiwu People′s Hospital from July 2019 to July 2020 were selected and divided into two groups according to random number table method,with 49 cases in each group.Both groups were given routine treatment,the control group was additionally treated with PS,and the observation group was additionally treated with Budesonide on the basis of PS treatment.The arterial blood gas status,ventilator related parameters,ventilation related indexes and adverse reactions were compared between the two groups.Results Before treatment,there were no significant differences in arterial blood gas index and ventilator related parameters between the two groups(P>0.05).The partial blood oxygen pressure(PaO2)and oxygenation index(OI)of the two groups after treatment were higher than those before treatment,and the partial blood carbon dioxide pressure(PaCO2)of the two groups after treatment was lower than that before treatment,the PaO2 and OI of the observation group after treatment were(81.79±6.79)mmHg and(283.69±19.13)mmHg,which were higher than those of the control group,which were(76.68±6.34)and(264.41±17.76)mmHg,PaCO2 of the observation group after treatment was(40.52±4.58)mmHg,lower than that of the control group of(45.31±4.62)mmHg,and the differences were statistically significant(P<0.05).After treatment,the peak inspiratory pressure(PIP),inhaled oxygen concentration(FiO2)and respiratory rate(RR)of the two groups were all lower than those before treatment,and the PIP,FiO2 and RR of the observation group were(17.89±1.86)cmH2O,(29.68±4.05)% and(35.42±4.31)times/min after treatment,which were lower than those in the control group of(19.65±2.02)cmH2O,(33.71±4.27)%,(40.28±4.65)times/min,and the differences were statistically significant(P<0.05).The invasive ventilation time of the observation group was(3.25±0.42)d,weaning time of the observation group was(27.69±3.65)d,and hospitalization time of the observation group was(40.13±5.62)d,which were all shorter than those of the control group of(4.51±0.86),(31.14±3.85)and(46.85±5.79)d,the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05),and no serious adverse reactions occurred in the two groups,which did not affect the treatment after symptomatic treatment.Conclusion PS combined with Budesonide can enhance the treatment effect of children with severe NRDS,improve the arterial blood gas index,correct the body′s hypoxia state,reduce the burden of respiratory support,and shorten the weaning time.It is safe and reliable.
京公网安备 11010502046607号